Unlock instant, AI-driven research and patent intelligence for your innovation.

Levobupivacaine hydrochloride crystal form A and preparation method thereof

A technology of levobupivacaine hydrochloride and crystal form, which is applied in the field of pharmaceutical preparation and achieves the effect of good performance and favorable transfer

Inactive Publication Date: 2016-05-18
SHANDONG QIDU PHARMA
View PDF6 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the obtained crystal form has not been characterized in the existing literature at present, so the inventor has carried out further research on the unreported crystal form of levobupivacaine hydrochloride

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Levobupivacaine hydrochloride crystal form A and preparation method thereof
  • Levobupivacaine hydrochloride crystal form A and preparation method thereof
  • Levobupivacaine hydrochloride crystal form A and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0020] Add 900mL of methyl ethyl ketone and 900mL of ethyl acetate into a 3L reaction kettle, add 300g of levobupivacaine hydrochloride crude product under stirring, and heat to 100g; ℃ and filtered it into another 3L reaction kettle while it was hot, cooled to 20 ℃ for 2.5 hours to crystallize, and then cooled to 0 ℃ for 6 hours to crystallize. After the crystallization was completed, a white solid was obtained by filtration, and then dried at 60° C. for 6 hours. Determined by X-powder diffraction, see figure 1 , the reflection angle 2θ has characteristic peaks at about 9.6786, 10.6164, 12.5864, 13.3324, 18.9888, 21.5685; detected by infrared absorption spectrum, see figure 2 , at 3103.46, 2875.86, 1674.21, 1537.27, 1473.62, 786.96cm -1 .

Embodiment 2

[0022] Add 2.1L of methyl ethyl ketone and 2.3L of ethyl acetate into a 5L reaction kettle, add 700g of levobupivacaine hydrochloride crude product under stirring, and heat to 80°C; after refluxing and dissolving, add 35g of silica gel and continue stirring for 1 hour; At 60°C-70°C, filter while hot into another 5L reactor, cool down to 20°C for crystallization for 2.5 hours, then cool down to 0°C for 6 hours for crystallization. After the crystallization was completed, a white solid was obtained by filtration, and then dried at 55° C. for 6 hours. Determined by X-powder diffraction, see image 3 , the reflection angle 2θ has characteristic peaks at about 9.7177, 10.6572, 12.6361, 13.3865, 19.0401, 21.6302; detected by infrared spectroscopy, see Figure 4 , at 3101.54, 2877, 79, 1674.21, 1539.20, 1473.62, 786.96cm -1 .

Embodiment 3

[0024] Add 2.7L of methyl ethyl ketone and 3L of ethyl acetate into a 10L reaction kettle, add 1000g of levobupivacaine hydrochloride crude product under stirring, and heat to 77°C; ℃~70℃, filtered while hot into another 10L reactor, cooled to 20℃ for crystallization for 2.5 hours, and then cooled to 0℃ for 6 hours for crystallization. After the crystallization was completed, a white solid was obtained by filtration, and then dried at 62° C. for 6 hours. Determined by X-powder diffraction, see Figure 5 , the reflection angle 2θ has characteristic peaks at about 9.7355, 10.6925, 12.6543, 13.4132, 19.0551, 21.6469; detected by infrared spectroscopy, see Figure 6 , at 3103.46, 2875.86, 1674.21, 1537.27, 1473.62, 786.96cm -1 .

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a levobupivacaine hydrochloride crystal form A and a preparation method thereof. The levobupivacaine hydrochloride crystal form A is characterized in that a reflection angle 2 theta of an X-ray powder diffraction pattern is in the ranges of 9.6-9.8, 10.6-10.8, 12.5-12.7, 13.3-13.5, 18.9-19.1 and 21.5-21.7, and the peak intensity is 100% when the reflection angle 2 theta is equal to 9.6-9.8. The crystal form is high in purity, high in yield and stable, and the preparation process is simple and easy to implement.

Description

technical field [0001] The invention relates to crystal form A of levobupivacaine hydrochloride and a preparation method thereof, belonging to the technical field of pharmaceutical preparation. Background technique [0002] The chemical name of levobupivacaine hydrochloride is S-(-)-1-butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide hydrochloride, and its structural formula is as follows: [0003] [0004] Levobupivacaine hydrochloride is a new type of long-acting amide local anesthetic, mainly used for surgical epidural block anesthesia. By increasing the nerve electrical stimulation threshold, delaying the propagation of nerve impulses, reducing the increase rate of action potentials, and blocking the generation and conduction of nerve impulses. The maintenance time of anesthesia is long, the muscles relax well, and a relatively stable depth of anesthesia can be maintained without multiple intraspinal medications during the operation; the dosage of anesthesia is sm...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D211/60
CPCC07D211/60C07B2200/13
Inventor 王孟朱建益张涛郑亮孟凡领
Owner SHANDONG QIDU PHARMA